Home

Letters, Testimony & Comments

IP Attache Program: BIO's Congressional Hearing Comments
  The U.S. Intellectual Property Rights Attaché Program has had significant success and holds immense promise in helping to...
June 27 2012
More than Myriad: Gene Patent Discussion Must Not Forget Industrial, Environmental, Food and Agricultural Biotech
On behalf of the 23 undersigned industrial, environmental, food and agricultural biotechnology companies, we write to express our...
June 11 2012
Supplemental Examination: BIO Comments on Patent Reform
From BIO’s perspective, Supplemental Examination may have significant benefits, because patents that undergo this process are...
March 25 2012
AIA Oath or Declaration: BIO Comments
Selected Excerpts: The vast majority of BIO’s members are small and medium sized enterprises that currently do not have products...
March 7 2012
USPTO Genetic Testing Study: BIO's Testimony
If a poor patient in Nevada doesn’t have access to an advanced molecular diagnostic test, and right across the border in California...
February 17 2012
USPTO Satellite Offices: Biotechnology Hubs Ideal Place
  January 30, 2012 Azam Khan Deputy Chief of Staff, Office of the Under Secretary and Director United States Patent and...
January 30 2012
China Patent Enforcement Comments to USPTO
By Electronic Submission Ip.policy@uspto.gov Office of Policy and External Affairs United States Patent and Trademark Office...
November 10 2011
International IP and Small Businesses: Novavax CEO Testifies on BIO's Behalf
October 27, 2011
By electronic submission Saurabh Vishnubhakat Attorney Advisor, Office of Chief Economist United States Patent and Trademark...
October 27 2011
Therasense USPTO Implementation: BIO Comments on the Revision of the Standard for the Duty to Disclose
October 19, 2011
The Honorable David Kappos Under Secretary of Commerce for Intellectual Property, Director of the U.S. Patent & Trademark Office...
October 19 2011
American Invents Act Manager's Amendment: BIO Strongly Supports
June 14, 2011
Dear Chairman Smith: On behalf of the Biotechnology Industry Organization (BIO), I am writing to express our strong support for your...
June 14 2011
Fee Diversion: BIO Joins Broad Coalition to Support End of Fee Diversion at PTO
June 13, 2011
Dear Speaker Boehner and Leader Pelosi: We write to express our unified support for Section 22 of H.R. 1249, “The America Invents...
June 13 2011
BIO Comments to USPTO on Incentivizing Humanitarian Technologies and Licensing Through the Intellectual Property System
November 19, 2010
Re: Request for Comments on Incentivizing Humanitarian Technologies and Licensing Through the Intellectual Property System, 75 Fed. Reg....
November 19 2010
Intellectual Property: New Mechanism for Deferring the Filing a Complete Patent Application if a Previous Provisional Patent Application was Filed and is Relied on by the Applicant
June 1, 2010
BIO questions about the utility and expected impact of the proposal, and why patent applicants should be debited with subtractions from...
June 1 2010
BIO's comments to the Patent and Trademark Office
March 20, 2009
March 20 2009
BIO's Comments to the US Patent and Trademark Office on Proposed Rule Changes Concerning Claims Containing Alternative Language
October 9, 2007
Attention: Kathleen Fonda Comments to Notice of Proposed Rulemaking Entitled: Examination of Patent Applications That Include Claims...
October 9 2007
Patent Law Harmonization
June 22, 2007
I'm writing on  behalf of the Biotechnology Industry Organization (BIO) in response to your invitation for public comments on...
June 22 2007
H.R. 1908, the Patent Reform Act of 2007
April 26, 2007
The Statement of the The Biotechnology Industry Organization On H.R. 1908, The Patent Reform Act of 2007 The United States House of...
April 26 2007
USPTO's proposed 5-year Strategic Plan
October 6, 2006
Perhaps no other industry is as dependent upon patents as is the biotech industry.  In 2004 alone, more than 10% of the PTO's...
October 6 2006
Comments to the USPTO on the proposed rule changes to Information Disclosure Statements
September 9, 2006
Attention: Hiram H. Bernstein Comments to Proposed Rulemaking Entitled: Changes to Information Disclosure Requirements and Other...
September 9 2006
Letter opposing proposed PTO changes to patent rules that would limit continuations and examined claims
May 2, 2006
May 2 2006
BIO Testimony on Patent Reform
September 16, 2005
September 16 2005
BIO Response to PTO's Green Paper
September 14, 2005
September 14 2005
BIO letter on Patent Reform
May 13, 2005
May 13 2005
Response to FTC Patent System Reform Recommendations
April 26, 2004
April 26 2004
Letter to James E. Rogan on Unity of Invention
December 5, 2003
December 5 2003
BIO Letter to the House Leadership supporting passage of H.R. 1561, the United States Patent and Trademark Fee Modernization Act of 2003
October 24, 2003
Dear House Leadership: On behalf of the Biotechnology Industry Organization (BIO), I urge you to seek prompt passage of H.R. 1561, the...
October 24 2003
Statement before the House Judiciary Subcommittee on the Courts, the Internet and Intellectual Property
April 3, 2003
April 3 2003
Letter from Jim Rogan, USPTO Director Opposing S. 812
July 30, 2002
July 30 2002
BIO Statement on Proposed PTO Fee Restructuring
July 25, 2002
July 25 2002
In Depth Legal Analysis of Proposed PTO Fee Restructuring
July 17, 2002
July 17 2002
Patent Law Harmonization: Letter to James Rogan
May 6, 2002
Under Secretary of Commerce for Intellectual Property and Director of the USPTO on Patent Harmonization
May 6 2002
Letter to James Rogan, Under Secretary of Commerce for Intellectual Property and Director of the USPTO on Patent Harmonization
May 6, 2002
May 6 2002
BIO letter to J. Dennis Hastert
November 5, 2001
November 5 2001

Letters, Testimony & Comments

IP Attache Program: BIO's Congressional Hearing Comments
June 27 2012
  The U.S. Intellectual Property Rights Attaché Program has had significant success and holds immense promise in helping to...
More than Myriad: Gene Patent Discussion Must Not Forget Industrial, Environmental, Food and Agricultural Biotech
June 11 2012
On behalf of the 23 undersigned industrial, environmental, food and agricultural biotechnology companies, we write to express our...
Supplemental Examination: BIO Comments on Patent Reform
March 25 2012
From BIO’s perspective, Supplemental Examination may have significant benefits, because patents that undergo this process are...
AIA Oath or Declaration: BIO Comments
March 7 2012
Selected Excerpts: The vast majority of BIO’s members are small and medium sized enterprises that currently do not have products...
USPTO Genetic Testing Study: BIO's Testimony
February 17 2012
If a poor patient in Nevada doesn’t have access to an advanced molecular diagnostic test, and right across the border in California...
More Letters, Testimony & Comments →

Press Releases

BIO Unveils Strategic Initiative to Speed Scientific Breakthroughs, Develop Cures and Grow the Bio-Economy
June 29 2011
WASHINGTON, D.C. (Wednesday, June 29, 2011) - The Biotechnology Industry Organization (BIO) released today a summary...
BIO Hosts U.S./China Biotechnology Examiner Workshop with U.S. Patent and Trademark Office and China’s State Intellectual Property Office
April 5 2011
WASHINGTON, D.C. (Tuesday, April 05, 2011) - The Biotechnology Industry Organization (BIO) hosted a U.S./China...
Director of U.S. Patent and Trademark Office to Speak at 2010 BIO International Convention
March 15 2010
WASHINGTON, D.C. (Monday, March 15, 2010) - David Kappos, Director of the U.S. Patent and Trademark Office and Under...
BIO Commends PTO Director for Withdrawal of Harmful Rules
October 8 2009
WASHINGTON, D.C. (Thursday, October 08, 2009) - Biotechnology Industry Organization (BIO) President and CEO Jim...
Temporary PTO Funding Option is Critical For Biotech Innovation and Jobs
July 8 2009
WASHINGTON, D.C. (Wednesday, July 08, 2009) - The following statement was issued today by the Biotechnology Industry...
More Press Releases →